Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics

References

• Tenchov R, Bird R, Curtze AE, et al. Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15(11):16982–17015.
   PubMed Web of Science ®Google Scholar
• Park H, Otte A, Park K. Evolution of drug delivery systems: from 1950 to 2020 and beyond. J Control Release. 2022;342:53–65.
   PubMed Web of Science ®Google Scholar
• El Sayed MM, Takata H, Shimizu T, et al. Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: appearance of an unexplained mechanism in the ABC phenomenon. J Control Release. 2020;323:102–109.
   PubMed Web of Science ®Google Scholar
• McSweeney MD, Price LSL, Wessler T, et al. Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG. J Control Release. 2019;311-312:138–146.
   PubMed Web of Science ®Google Scholar
• Krishnan N, Fang RH, Zhang L. Engineering of stimuli-responsive self-assembled biomimetic nanoparticles. Adv Drug Deliv Rev. 2021;179:114006.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang D, Duan Y, et al. Cellular Nanosponges for Biological Neutralization. Adv Mater. 2022;34:2107719.•• The first report of RBC-NPs which opened the era of cell membrane-based biomimetic nanoparticles.
   Google Scholar
• Hu CM, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A. 2011;108(27):10980–10985.
   PubMed Web of Science ®Google Scholar
• Ihler GM, Glew RH, Schnure FW. Enzyme loading of erythrocytes. Proc Natl Acad Sci U S A. 1973;70(9):2663–2666.
   PubMed Web of Science ®Google Scholar
• Wang X, Li H, Liu X, et al. Enhanced Photothermal Therapy of Biomimetic Polypyrrole Nanoparticles Through Improving Blood Flow Perfusion. Biomaterials. 2017;143:130.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Luo Z, Men Y, et al. Red Blood Cell Membrane-Camouflaged Melanin Nanoparticles for Enhanced Photothermal Therapy. Biomaterials. 2017;143:29.
   PubMed Web of Science ®Google Scholar
• Xie J, Shen Q, Huang K, et al. Oriented Assembly of Cell-Mimicking Nanoparticles vi a Molecular Affinity Strategy for Targeted Drug Delivery. ACS Nano. 2019;13(5):5268–5277.
   PubMed Web of Science ®Google Scholar
• Huang J, Lai W, Wang Q, et al. Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles. Int J Nanomedicine. 2021;16:7497–7515.
   PubMed Web of Science ®Google Scholar
• Piao JG, Wang L, Gao F, et al. Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. ACS Nano. 2014;8(10):10414–10425.
   PubMed Web of Science ®Google Scholar
• Ren X, Zheng R, Fang X, et al. Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy. Biomaterials. 2016;92:13–24.
   PubMed Web of Science ®Google Scholar
• Li C, Yang XQ, An J, et al. Red blood cell membrane-enveloped O(2) self-supplementing biomimetic nanoparticles for tumor imaging-guided enhanced sonodynamic therapy. Theranostics. 2020;10:867–879.
   PubMed Web of Science ®Google Scholar
• Liu JM, Zhang DD, Fang GZ, et al. Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery. Biomaterials. 2018;165:39–47.
   PubMed Web of Science ®Google Scholar
• Chugh V, Vijaya Krishna K, Pandit A. Cell membrane-coated mimics: a methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation. ACS Nano. 2021;15(11):17080–17123.
   Web of Science ®Google Scholar
• Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24(3):179–191.
   PubMed Web of Science ®Google Scholar
• Copp JA, Fang RH, Luk BT, et al. Clearance of pathological antibodies using biomimetic nanoparticles. Proc Natl Acad Sci U S A. 2014;111(37):13481–13486.
   PubMed Web of Science ®Google Scholar
• Pang Z, Hu CMJ, Fang RH, et al. Detoxification of organophosphate poisoning using nanoparticle bioscavengers. ACS Nano. 2015;9(6):6450.
   PubMed Web of Science ®Google Scholar
• Rao L, Cai B, Bu LL, et al. Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano. 2017;11(4):3496–3505.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao W, Fang RH, et al. Synthesis of nanogels via cell membrane-templated polymerization. Small. 2015;11(34):4309–4313.
   PubMed Web of Science ®Google Scholar
• Zhen X, Cheng P, Pu K. Recent advances in cell membrane-camouflaged nanoparticles for cancer phototherapy. Small. 2019;15(1):e1804105.
   PubMed Web of Science ®Google Scholar
• Thamphiwatana S, Angsantikul P, Escajadillo T, et al. Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management. Proc Natl Acad Sci U S A. 2017;114(43):11488–11493.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Wang J, Lang T, et al. T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy. Nat Nanotechnol. 2021;16(11):1271–1280.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Dehaini D, Zhang Y, et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol. 2018;13(12):1182–1190.
   PubMed Web of Science ®Google Scholar
• Li R, He Y, Zhu Y, et al. Route to rheumatoid arthritis by macrophage derived microvesicle-coated nanoparticles. Nano Lett. 2019;19(1):124–134.
   PubMed Web of Science ®Google Scholar
• Kroll AV, Fang RH, Jiang Y, et al. Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity. Adv Mater. 2017;29:1703969.
   Web of Science ®Google Scholar
• Guo P, Huang J, Zhao Y, et al. Nanomaterial preparation by extrusion through nanoporous membranes. Small. 2018;14(18):e1703493.
   PubMed Web of Science ®Google Scholar
• Yang F, Cabe MH, Ogle SD, et al. Optimization of critical parameters for coating of polymeric nanoparticles with plasma membrane vesicles by sonication. Sci Rep. 2021;11(1):23996.
   PubMed Web of Science ®Google Scholar
• Niculescu AG, Chircov C, Bîrcă AC, et al. Fabrication and applications of microfluidic devices: a review. Int J Mol Sci. 2021;23(1):22.
   PubMedGoogle Scholar
• Molinaro R, Evangelopoulos M, Hoffman JR, et al. Design and development of biomimetic nanovesicles using a microfluidic approach. Adv Mater. 2018;30(15):e1702749.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Chen W, et al. Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection. J Control Release. 2017;263:185–191.
   PubMed Web of Science ®Google Scholar
• Cheng MJ, Kumar R, Sridhar S, et al. Endothelial glycocalyx conditions influence nanoparticle uptake for passive targeting. Int J Nanomedicine. 2016;11:3305–3315.
   PubMed Web of Science ®Google Scholar
• Xia Q, Zhang Y, Li Z, et al. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B. 2019;9(4):675–689.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen X. Sialic acid metabolism and sialyltransferases: natural functions and applications. Appl Microbiol Biotechnol. 2012;94(4):887–905.
   PubMed Web of Science ®Google Scholar
• Luk BT, Hu CM, Fang RH, et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale. 2014;6(5):2730–2737.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang B, Shen S, et al. Tumor microenvironment modulation by cyclopamine improved photothermal therapy of biomimetic gold nanorods for pancreatic ductal adenocarcinomas. ACS Appl Mater Interfaces. 2017;9(37):31497–31508.
   PubMed Web of Science ®Google Scholar
• Gao W, Hu CM, Fang RH, et al. Surface functionalization of gold nanoparticles with red blood cell membranes. Adv Mater. 2013;25(26):3549–3553.
   PubMed Web of Science ®Google Scholar
• Liu B, Wang W, Fan J, et al. RBC membrane camouflaged Prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer. Biomaterials. 2019;217:119301.
   PubMed Web of Science ®Google Scholar
• He Y, Li R, Li H, et al., Erythroliposomes: integrated hybrid nanovesicles composed of erythrocyte membranes and artificial lipid membranes for pore-forming toxin clearance. ACS Nano. 2019;13(4):4148–4159.
   PubMed Web of Science ®Google Scholar
• Liu L, Bai X, Martikainen M-V, et al. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles. Nat Commun. 2021;12(1):5726.
   PubMed Web of Science ®Google Scholar
• Li H, Jin K, Luo M, et al. Size dependency of circulation and biodistribution of biomimetic nanoparticles: red blood cell membrane-coated nanoparticles. Cells. 2019;8(8):881.
   PubMed Web of Science ®Google Scholar
• Liu Y, Luo J, Chen X, et al. Cell membrane coating technology: a promising strategy for biomedical applications. Nanomicro Lett. 2019;11(1):100.
   PubMed Web of Science ®Google Scholar
• Weingart J, Vabbilisetty P, Sun X-L. Membrane mimetic surface functionalization of nanoparticles: methods and applications. Adv Colloid Interface Sci. 2013;197-198:68–84.
   PubMed Web of Science ®Google Scholar
• Xie X, Wang H, Williams GR, et al. Erythrocyte membrane cloaked curcumin-loaded nanoparticles for enhanced chemotherapy. Pharmaceutics. 2019;11(9) :429.
   Web of Science ®Google Scholar
• Fu Q, Lv P, Chen Z, et al. Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane. Nanoscale. 2015;7(9):4020–4030.
   PubMed Web of Science ®Google Scholar
• Gao L, Wang H, Nan L, et al., Erythrocyte membrane-wrapped ph sensitive polymeric nanoparticles for non-small cell lung cancer therapy. Bioconjug Chem. 2017;28(10):2591–2598.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang D, Song Q, et al. Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma. ACS Nano. 2015;9(7):6918–6933.
   PubMed Web of Science ®Google Scholar
• Xuan M, Shao J, Zhao J, et al. Magnetic mesoporous silica nanoparticles cloaked by red blood cell membranes: applications in cancer therapy. Angew Chem Int Ed Engl. 2018;57(21):6049–6053.
   PubMed Web of Science ®Google Scholar
• Wu S-H, Hsieh -C-C, Hsu S-C, et al. RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy. J Adv Res. 2021;30:185–196.
   PubMed Web of Science ®Google Scholar
• Gaudreault RC, Bellemare B, Lacroix J. Erythrocyte membrane-bound daunorubicin as a delivery system in anticancer treatment. Anticancer Res. 1989;9(4):1201–1205.
   PubMed Web of Science ®Google Scholar
• Zhang F, Li F, G-h L, et al. Engineering magnetosomes for ferroptosis/immunomodulation synergism in cancer. ACS Nano. 2019;13(5):5662–5673.
   PubMed Web of Science ®Google Scholar
• Wang J, Ding J, He L, et al. Erythrocyte membrane-coated polypeptide nanogel with long circulation and intracellular drug release for prostate cancer therapy. Nanomedicine. 2018;14:1749–1750.
   Google Scholar
• Wen Q, Zhang Y, Muluh TA, et al. Erythrocyte membrane-camouflaged gefitinib/albumin nanoparticles for tumor imaging and targeted therapy against lung cancer. Int J Biol Macromol. 2021;193:228–237.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang B, Zhang L, et al. Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma. Artif Cells Nanomed Biotechnol. 2018;46(sup1):1088–1101.
   PubMed Web of Science ®Google Scholar
• Zhang X, Angsantikul P, Ying M, et al. Remote loading of small molecule therapeutics into cholesterol-enriched cell membrane-derived vesicles. Angew Chem Int Ed Engl. 2017;56(45): 14075–14079.
   PubMed Web of Science ®Google Scholar
• Fan Z, Zhou H, Li PY, et al., Structural elucidation of cell membrane-derived nanoparticles using molecular probes. J Mater Chem B. 2014;2(46):8231–8238.
   PubMed Web of Science ®Google Scholar
• Chai Z, Ran D, Lu L, et al. Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma. ACS Nano. 2019;13(5):5591–5601.
   PubMed Web of Science ®Google Scholar
• Xu L, Wu S, Zhou X. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma. J Biomater Appl. 2018;33(1):72–81.
   PubMed Web of Science ®Google Scholar
• Rao L, Meng QF, Huang Q, et al. Photocatalytic degradation of cell membrane coatings for controlled drug release. Adv Healthc Mater. 2016;5(12):1420–1427.
   PubMed Web of Science ®Google Scholar
• Chen C, Ma W, Zhao J. Semiconductor-mediated photodegradation of pollutants under visible-light irradiation. Chem Soc Rev. 2010;39(11):4206–4219.
   PubMed Web of Science ®Google Scholar
• Zhu DM, Xie W, Xiao YS, et al. Erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy. Nanotechnology. 2018;29(8):084002.
   PubMed Web of Science ®Google Scholar
• Liu W, Ruan M, Wang Y, et al. Light-triggered biomimetic nanoerythrocyte for tumor-targeted lung metastatic combination therapy of malignant melanoma. Small. 2018;14(38):e1801754.
   PubMed Web of Science ®Google Scholar
• Su J, Sun H, Meng Q, et al. Bioinspired nanoparticles with NIR-controlled drug release for synergetic chemophotothermal therapy of metastatic breast cancer. Adv Funct Mater. 2016;26(41):7495–7506.
   Web of Science ®Google Scholar
• Zhang L, Wang Z, Zhang Y, et al. Erythrocyte membrane cloaked metal-organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy. ACS Nano. 2018;12(10):10201–10211.
   PubMed Web of Science ®Google Scholar
• Lin Y, Zhong Y, Chen Y, et al. Ligand-modified erythrocyte membrane-cloaked metal-organic framework nanoparticles for targeted antitumor therapy. Mol Pharm. 2020;17(9):3328–3341.
   PubMed Web of Science ®Google Scholar
• Cai R, Chen C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv Mater. 2019;31(45):e1805740.
   PubMed Web of Science ®Google Scholar
• Monopol IMP, Åberg C, Salvati A, et al. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012;7(12):779–786.
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28–51.
   PubMed Web of Science ®Google Scholar
• Schöttler S, Becker G, Winzen S, et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat Nanotechnol. 2016;11(4):372–377.
   PubMed Web of Science ®Google Scholar
• Peng S, Ouyang B, Men Y, et al. Biodegradable zwitterionic polymer membrane coating endowing nanoparticles with ultra-long circulation and enhanced tumor photothermal therapy. Biomaterials. 2020;231:119680.
   PubMed Web of Science ®Google Scholar
• Miao Y, Yang Y, Guo L, et al. Cell membrane-camouflaged nanocarriers with biomimetic deformability of erythrocytes for ultralong circulation and enhanced cancer therapy. ACS Nano. 2022;16(4):6527–6540.
   Web of Science ®Google Scholar
• Rao L, Meng Q-F, L-L B, et al. Erythrocyte membrane-coated upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging. ACS Appl Mater Interfaces. 2017;9(3):2159–2168.
   PubMed Web of Science ®Google Scholar
• Oldenborg PA, Zheleznyak A, Fang YF, et al. Role of CD47 as a marker of self on red blood cells. Science. 2000;288(5473):2051–2054.
   PubMed Web of Science ®Google Scholar
• Molina H, Miwa T, Zhou L, et al. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Blood. 2002;100(13):4544–4549.
   PubMed Web of Science ®Google Scholar
• Kim DD, Miwa T, Kimura Y, et al. Deficiency of decay-accelerating factor and complement receptor 1–related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg. Blood. 2008;112(4):1109–1119.
   PubMed Web of Science ®Google Scholar
• Miwa T, Zhou L, Hilliard B, et al. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood. 2002;99(10):3707–3716.
   PubMed Web of Science ®Google Scholar
• Fam SY, Chee CF, Yong CY, et al. Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials (Basel). 2020;10(4):787.
   PubMedGoogle Scholar
• Vankayala R, Mac JT, Burns JM, et al. Biodistribution and toxicological evaluation of micron- and nano-sized erythrocyte-derived optical particles in healthy Swiss Webster mice. Biomater Sci. 2019;7(5):2123–2133.
   PubMed Web of Science ®Google Scholar
• Luk BT, Fang RH, C-m J H, et al. Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors. Theranostics. 2016;6(7):1004–1011.
   PubMed Web of Science ®Google Scholar
• Tang L, He S, Yin Y, et al. Combination of nanomaterials in cell-based drug delivery systems for cancer treatment. Pharmaceutics. 2021;14(1):13.
   PubMedGoogle Scholar
• Liang X, Wang H, Grice JE, et al. Physiologically based pharmacokinetic model for long-circulating inorganic nanoparticles. Nano Lett. 2016;16(2):939–945.
   PubMed Web of Science ®Google Scholar
• Sun D, Chen J, Wang Y, et al. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery. Theranostics. 2019;9(23):6885–6900.
   PubMed Web of Science ®Google Scholar
• Zou Y, Liu Y, Yang Z, et al. Effective and targeted human orthotopic glioblastoma Xenograft therapy via a multifunctional biomimetic nanomedicine. Adv Mater. 2018;30(51):e1803717.
   PubMed Web of Science ®Google Scholar
• Zhang Y-N, Poon W, Tavares AJ, et al. Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J Control Release. 2016;240:332–348.
   PubMed Web of Science ®Google Scholar
• Poon W, Zhang YN, Ouyang B, et al. Elimination pathways of nanoparticles. ACS Nano. 2019;13(5):5785–5798.
   PubMed Web of Science ®Google Scholar
• Zhang A, Meng K, Liu Y, et al. Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences. Adv Colloid Interface Sci. 2020;284:102261.
   PubMed Web of Science ®Google Scholar
• Atukorale PU, Yang Y-S, Bekdemir A, et al. Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes. Nanoscale. 2015;7(26):11420–11432.
   PubMed Web of Science ®Google Scholar
• Yang G, Phua SZF, Bindra AK, et al. Degradability and clearance of inorganic nanoparticles for biomedical applications. Adv Mater. 2019;31(10):e1805730.
   PubMed Web of Science ®Google Scholar
• Zhu M, Nie G, Meng H, et al. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc Chem Res. 2013;46(3):622–631.
   PubMed Web of Science ®Google Scholar
• Jia W, Burns JM, Villantay B, et al. Intravital vascular phototheranostics and real-time circulation dynamics of micro- and nanosized erythrocyte-derived carriers. ACS Appl Mater Interfaces. 2020;12(1):275–287.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Andresen TL. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol. 2012;52(1):481–503.
   PubMedGoogle Scholar
• Zhao X, Yan C. Research progress of cell membrane biomimetic nanoparticles for tumor therapy. Nanoscale Res Lett. 2022;17(1):36.
   PubMed Web of Science ®Google Scholar
• Oroojalian F, Beygi M, Baradaran B, et al. Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small. 2021;17(12):e2006484.
   PubMed Web of Science ®Google Scholar
• Zhu M, Yang M, Zhang J, et al. Immunogenic cell death induction by ionizing radiation. Front Immunol. 2021;12:705361.
   PubMed Web of Science ®Google Scholar
• Wang S, Yin Y, Song W, et al. Red-blood-cell-membrane-enveloped magnetic nanoclusters as a biomimetic theranostic nanoplatform for bimodal imaging-guided cancer photothermal therapy. J Mater Chem B. 2020;8(4):803–812.
   PubMed Web of Science ®Google Scholar
• Su J, Sun H, Meng Q, et al. Enhanced blood suspensibility and laser-activated tumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with erythrocyte membranes. Theranostics. 2017;7(3):523–537.
   PubMed Web of Science ®Google Scholar
• Liu WL, Liu T, Zou MZ, et al. Aggressive man-made red blood cells for hypoxia-resistant photodynamic therapy. Adv Mater. 2018;30(35):e1802006.
   PubMed Web of Science ®Google Scholar
• Ren H, Liu J, Li Y, et al. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy. Acta Biomater. 2017;59:269–282.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu Y, Ning B, et al. Intravenous delivery of living listeria monocytogenes elicits gasdmermin-dependent tumor pyroptosis and motivates anti-tumor immune response. ACS Nano. 2022;16(3):4102–4115.
   PubMed Web of Science ®Google Scholar
• Liu W, Wu J, Ji X, et al. Advanced biomimetic nanoreactor for specifically killing tumor cells through multi-enzyme cascade. Theranostics. 2020;10(14):6245–6260.
   PubMed Web of Science ®Google Scholar
• Ding L, Wu Y, Wu M, et al. Engineered red blood cell biomimetic nanovesicle with oxygen self-supply for near-infrared-ii fluorescence-guided synergetic chemo-photodynamic therapy against hypoxic tumors. ACS Appl Mater Interfaces. 2021;13(44):52435–52449.
   Web of Science ®Google Scholar
• Sousa-Junior AA, Mendanha SA, Carrião MS, et al. Predictive model for delivery efficiency: erythrocyte membrane-camouflaged magnetofluorescent nanocarriers study. Mol Pharm. 2020;17(3):837–851.
   PubMed Web of Science ®Google Scholar
• Lv P, Liu X, Chen X, et al. Genetically engineered cell membrane nanovesicles for oncolytic adenovirus delivery: a versatile platform for cancer virotherapy. Nano Lett. 2019;19(5):2993–3001.
   PubMed Web of Science ®Google Scholar
• Gotwals P, Cameron S, Cipolletta D, et al. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat Rev Cancer. 2017;17(5):286–301.
   PubMed Web of Science ®Google Scholar
• El-Hussein A, Manoto SL, Ombinda-Lemboumba S, et al., A review of chemotherapy and photodynamic therapy for lung cancer treatment. Anticancer Agents Med Chem. 2021;21(2):149–161.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CM, Chen KN, et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale. 2013;5(19):8884–8888.
   PubMed Web of Science ®Google Scholar
• Chen H, Sha H, Zhang L, et al. Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein. Int J Nanomedicine. 2018;13:5347–5359.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qian H, Huang J, et al. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Int J Nanomedicine. 2018;13:4961–4975.
   PubMed Web of Science ®Google Scholar
• Q LJ, Zhao RX, Yang FM, et al. An erythrocyte membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of breast cancer. J Mater Chem B. 2022;10(12):2047–2056.
   PubMed Web of Science ®Google Scholar
• Sun R, Ge Y, Liu H, et al. Erythrocyte membrane-encapsulated glucose oxidase and manganese/ferrite nanocomposite as a biomimetic “all in one” nanoplatform for cancer therapy. ACS Appl Bio Mater. 2021;4(1):701–710.
   Google Scholar
• Sung SY, Su YL, Cheng W, et al. Graphene quantum dots-mediated theranostic penetrative delivery of drug and photolytics in deep tumors by targeted biomimetic nanosponges. Nano Lett. 2019;19(1):69–81.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xia Q, Wu T, et al. A novel multi-functionalized multicellular nanodelivery system for non-small cell lung cancer photochemotherapy. J Nanobiotechnology. 2021;19(1):245.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shi C, Cao J. Biomimetic phototherapy in cancer treatment: from synthesis to application. Drug Deliv. 2021;28(1):2085–2099.
   PubMed Web of Science ®Google Scholar
• Alzeibak R, Mishchenko TA, Shilyagina NY, et al. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. J Immunother Cancer. 2021;9(1):e001926.
   PubMed Web of Science ®Google Scholar
• Correia JH, Rodrigues JA, Pimenta S, et al. Photodynamic therapy review: principles, photosensitizers, applications, and future directions. Pharmaceutics. 2021;13:1332.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Y, Liu J, et al. Erythrocyte membrane bioengineered nanoprobes via indocyanine green-directed assembly for single NIR laser-induced efficient adynamic/photothermal theranostics. J Control Release. 2021;335:345–358.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhao D, Wang G, et al. Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development. Acta Pharm Sin B. 2020;10(8):1382–1396.
   PubMed Web of Science ®Google Scholar
• Gao S, Zheng P, Li Z, et al. Biomimetic O(2)-Evolving metal-organic framework nanoplatform for highly efficient photodynamic therapy against hypoxic tumor. Biomaterials. 2018;178:83–94.
   PubMed Web of Science ®Google Scholar
• Li J, Wang S, Lin X, et al. Red blood cell-mimic nanocatalyst triggering radical storm to augment cancer immunotherapy. Nanomicro Lett. 2022;14(1):57.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Liu Y, Guo R, et al. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors. Biomaterials. 2019;192:292–308.
   PubMed Web of Science ®Google Scholar
• Ding H, Lv Y, Ni D, et al. Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer. Nanoscale. 2015;7(21):9806–9815.
   PubMed Web of Science ®Google Scholar
• Yang K, Xu H, Cheng L, et al. In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv Mater. 2012;24(41):5586–5592.
   PubMed Web of Science ®Google Scholar
• Yu W, He X, Yang Z, et al. Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis. Biomaterials. 2019;217:119309.
   PubMed Web of Science ®Google Scholar
• Couzin-Frankel J. Breakthrough of the year 2013 Cancer immunotherapy. Science. 2013;342:1432–1433.
   PubMed Web of Science ®Google Scholar
• Melancon MP, Zhou M, Li C. Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res. 2011;44(10):947–956.
   PubMed Web of Science ®Google Scholar
• Han S, Wang W, Wang S, et al. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages. Nanoscale. 2019;11(42):20206–20220.
   PubMed Web of Science ®Google Scholar
• Lin H, Gao S, Dai C, et al. A two-dimensional biodegradable niobium carbide (MXene) for photothermal tumor eradication in NIR-I and NIR-II biowindows. J Am Chem Soc. 2017;139(45):16235–16247.
   PubMed Web of Science ®Google Scholar
• Cieslewicz M, Tang J, L YJ, et al. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci U S A. 2013;110(40):15919–15924.
   PubMed Web of Science ®Google Scholar
• Liang X, Ye X, Wang C, et al. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J Control Release. 2019;296:150–161.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yu X, Thamphiwatana SD, et al. Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy. Acta Pharm Sin B. 2020;10(11):2054–2074.
   PubMed Web of Science ®Google Scholar
• Qiu M, Wang D, Liang W, et al. Novel concept of the smart NIR-light-controlled drug release of black phosphorus nanostructure for cancer therapy. Proc Natl Acad Sci U S A. 2018;115(3):501–506.
   PubMed Web of Science ®Google Scholar
• Gao F, Tang Y, Liu WL, et al. Intra/Extracellular Lactic Acid Exhaustion For Synergistic Metabolic Therapy And Immunotherapy Of Tumors. Adv Mater. 2019;31(51):e1904639.
   PubMed Web of Science ®Google Scholar
• Gao M, Liang C, Song X, et al. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy. Adv Mater. 2017;29(35):1701429.
   Web of Science ®Google Scholar
• Zhuang J, Ying M, Spiekermann K, et al. Biomimetic nanoemulsions for oxygen delivery in vivo. Adv Mater. 2018;30(49):e1804693.
   PubMed Web of Science ®Google Scholar
• Garg AD, More S, Rufo N, et al. Trial watch: immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology. 2017;6(12):e1386829.
   PubMed Web of Science ®Google Scholar
• Song Q, Yin Y, Shang L, et al. Tumor microenvironment responsive nanogel for the combinatorial antitumor effect of chemotherapy and immunotherapy. Nano Lett. 2017;17(10):6366–6375.
   PubMed Web of Science ®Google Scholar